USA update on paclitaxel in ovarian cancer : Campaign against ovarian cancerOZOLS, R. F.Annals of medicine (Helsinki). 1995, Vol 27, Num 1, pp 127-130, issn 0785-3890Article

Cancer épithélial de l'ovaire : données actuelles = Epithelial ovarian cancer: an updateOZOLS, R. F.Bulletin du cancer. 1993, Vol 80, Num 11, pp 955-970, issn 0007-4551Article

Advances in the chemotherapy of gynecologic malignanciesOZOLS, R. F.Hematological oncology. 1992, Vol 10, Num 1, pp 43-51, issn 0278-0232Conference Paper

Role of carboplatin in ovarian cancer : current results and thoughts for the futureOZOLS, R. F.Acta obstetricia et gynecologica Scandinavica. Supplement. 1992, Vol 71, Num 155, pp 75-77, issn 0300-8835Conference Paper

Molecular and clinical advances in anticancer drug resistanceOZOLS, R. F.Cancer treatment and research. 1991, Vol 57, pp 1-295, issn 0927-3042Serial Issue

Chemotherapy for advanced epithelial ovarian cancerOZOLS, R. F.Hematology/oncology clinics of North America. 1992, Vol 6, Num 4, pp 879-894, issn 0889-8588Article

Ovarian cancer : new clinical approachesOZOLS, R. F.Cancer treatment reviews. 1991, Vol 18, pp 77-83, issn 0305-7372, 7 p., SUPAArticle

Progress in ovarian cancer: an overview and perspectiveOZOLS, R. F.European journal of cancer. Supplement (1990). 2003, Vol 1, Num 2, pp 43-55, issn 1359-6349, 13 p.Article

Research directions in epithelial ovarian cancerOZOLS, R. F.Gynecologic oncology (Print). 1994, Vol 55, Num 3, pp S168-S173, issn 0090-8258, 2Conference Paper

Carboplatin and paclitaxel in ovarian cancerOZOLS, R. F.Seminars in oncology. 1995, Vol 22, Num 3, pp 78-83, issn 0093-7754, SUP6Conference Paper

Genitourinary malignancyHUDES, G. R; OZOLS, R. F; GIANTONIO, B et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 531-554, issn 0921-4410Article

Paclitaxel (taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancerOZOLS, R. F.Seminars in oncology. 2000, Vol 27, Num 3, pp 3-7, issn 0093-7754, SUP7Conference Paper

Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancerOZOLS, R. F.Seminars in oncology. 1995, Vol 22, Num 6, pp 1-6, issn 0093-7754, SUP15Article

Chemotherapy of ovarian cancerOZOLS, R. F.Cancer treatment and research. 1998, Vol 95, pp 218-234, issn 0927-3042Article

Chemotherapy of ovarian cancerOZOLS, R. F; YOUNG, R. C.Seminars in oncology. 1991, Vol 18, Num 3, pp 222-232, issn 0093-7754Article

Chemotherapy for ovarian cancerOZOLS, R. F.Seminars in oncology. 1999, Vol 26, Num 6, pp 34-40, issn 0093-7754, SUP18Conference Paper

Genitourinary malignancyGIANTONIO, B; OZOLS, R. F; HUDES, G. R et al.Cancer chemotherapy and biological response modifiers annual. 1993, Vol 14, pp 498-529, issn 0921-4410Article

Chemotherapy of advanced ovarian cancerMCGUIRE, W. P; OZOLS, R. F.Seminars in oncology. 1998, Vol 25, Num 3, pp 340-348, issn 0093-7754Article

Future directions in the chemotherapy of ovarian cancerOZOLS, R. F.Seminars in oncology. 1997, Vol 24, Num 5, pp S15-86, issn 0093-7754, -S15-90, SUP15Conference Paper

Genitourinary cancerHUDES, G. R; OZOLS, R. F; SCHILDER, R. J et al.Cancer chemotherapy and biological response modifiers annual. 1991, Vol 12, pp 509-548, issn 0921-4410, 40 p.Article

Intraperitoneal chemotherapyOZOLS, R. F; MYERS, C. E; YOUNG, R. C et al.Annals of internal medicine. 1984, Vol 101, Num 1, pp 118-120, issn 0003-4819Article

Paclitaxel plus carboplatin in the treatment of ovarian cancerOZOLS, R. F.Seminars in oncology. 1999, Vol 26, Num 1, pp 84-89, issn 0093-7754, SUP2Conference Paper

Resistance to alkylating agents and cisplatin : insights from ovarian carcinoma model systemsPEREZ, R. P; HAMILTON, T. C; OZOLS, R. F et al.Pharmacology & therapeutics (Oxford). 1990, Vol 48, Num 1, pp 19-27, issn 0163-7258, 9 p.Article

The role of gemcitabine in the treatment of ovarian cancerOZOLS, R. F.Seminars in oncology. 2000, Vol 27, Num 1, pp 40-47, issn 0093-7754, SUP2Article

Management of advanced ovarian cancer consensus summaryOZOLS, R. F.Seminars in oncology. 2000, Vol 27, Num 3, pp 47-49, issn 0093-7754, SUP7Conference Paper